Loading...

Εκπαιδευτικά προγράμματα

Καταχωρήθηκε: Πέμπτη 19 Ιούλ 2018
Scope: To update the current treatment management of CLL in the elderly. Presenter: Dr Spyridis Participants: Prof. Spyridonidis, Dr Liga, Dr Aggelinas.
Καταχωρήθηκε: Τετάρτη 18 Ιούλ 2018
Based on a case we discussed the current treatment guidelines for essential thrombocythemia. Dr Spyridis presented the current How I treat Blood paper. Presenter: Dr Spyridis Participants: Prof: Spyridonidis, Dr Liga, Dr Aggelinas
Καταχωρήθηκε: Τετάρτη 11 Ιούλ 2018
We discussed a recent review of the Treatment Options for Carbapenem- Resistant Gram-Negative Infections. We additionally reviewed our current policy in treating these infections and implemented a new policy. Presenter: Prof. Marangos Participants: Prof. Spyridonidis, Dr Spyridis, Dr Liga, Dr Aggelinas.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
We discussed novel insights regarding the pathophysiology of CRS after CART therapy published in Nature Medicine. Activation of macrophages plays a major role.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: The Hellenic experience of the use of BV in relapsed HD was presented. The need for transplant after achieving some disease control was discussed. Presenter: Prof. Spyridonidis. Participants: Dr Liga, Dr Spyridis, Dr Aggelinas.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: We discussed the legislation about SEC and other terms such as GRID. The legislation was presented, especially the specific issue regarding BMT units in Greece which will be presented in EU TE Compenidum. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: To understand how PTCY works. We reviewed the current literature of PTCY after related or unrelated Tx. We discussed that the data are premature in order to adopt this strategy. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: To understand how PTCY works. We reviewed the current literature of PTCY after related or unrelated Tx. We discussed that the data are premature in order to adapt this strategy. Presenter: Prof. Spyridonidis. Participants: Dr Liga, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: To present the analysis of our transplant strategy. Results of the analysis of about 100 transplants is shown. Dr Maria Liga presented us her database. Prof. Spyridonidis explained how the data were analysed. The decision to add Cellcept in the case of a...
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: The use of TKIs post transplant to prevent relapse. A recent paper describing how sorafenob in mflt3 mutant AML promotes the local GVL effect is presented.  Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: Our current research paper in CLL published in Blood Advances was presented. Further goals were discussed. Presenter: Prof. Spyridonidis. Participants: Dr Liga, Dr Spyridis, Dr Aggelinas.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: To learn how to calculate EFS,OS, TRM, how to create Kaplan Meier curves and CI curves. The difference between CI and Kapolan Meier was discussed. Corresponding literature from ALPWP EBMT is provided. Presenter: Prof. Spyridonidis. Participants: Dr Liga, Dr Spyridis, Dr Aggelinas.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: To learn the differences between RIC, RTC, MAC, NMA, etc. Corresponding literature is provided. Presenter: Prof. Spyridonidis. Participants: Dr Liga, Dr Spyridis, Dr Aggelinas
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: To learn how to deceide whether we should get an older person to transplant. Literature and cases are presented. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: To understand the structure of donor registries. Learn corresponding terminology. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal:To learn about Bite, inotuzumab and CART therapies. Presenter: Prof. Spyridonidis. Participants: Dr Liga, Dr Spyridis, Dr Aggelinas
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: Which graft is better to use in haplo PTCY transplant? Dr Liga presented the current literature. We deceide the following policy CR-1 BM, advanced disease PBSC. Presenter: Dr Liga Participants: Prof. Spyridonidis, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: An overview of the haplo PTCY platform. Presenter: Dr Liga. Participants: Prof. Spyridonidis, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou.
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: Principles of Donor selection. Quiz and examples were shown. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Triantafyllou  
Καταχωρήθηκε: Δευτέρα 09 Ιούλ 2018
Goal: to get an overview of current cellular therapies and learn where we stand. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas, Dr Triantafyllou
Βρέθηκαν 279 αποτελέσματα. Σελίδα 9 από 14
Σελίδα << < [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] > >>
 

 

Τηλέφωνα Επικοινωνίας:

 

Γραμματεία MMMO: 2613 603506 (ασθενείς), 2613 604062 (Γραμματεία Διευθυντή) 
Fax : 2613 604066,
email (για ιατρούς): transplant@upatras.gr,
email (για ασθενείς): mmak@upatras.gr
email (για θέματα κλινικών μελετών) : gcppatras@gmail.com
Μονάδα Μεταμόσχευσης (Νοσηλεία): 2613 603 261
Γραφείο Ιατρών: 2613 604064, 2613 604065,
Εφημερεύων Ιατρός: 2610 999111 (τηλ. κέντρο ΠΓΝΠ)

 

βρείτε μας στο χάρτη

 

Login / Sitemap

 

© Copyright 2015 - 2021 Μονάδα Μεταμόσχευσης Μυελού των Οστών Πάτρας